Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › USP7 inhibitors for treating multiple myeloma

USP7 inhibitors for treating multiple myeloma

US Patent 11465983 · Granted Oct 11, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

USP7 inhibition2025
Modulating gabarap to modulate immunogenic cell death2024
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD32024
Methods to treat lymphoplasmacytic lymphoma2024
Methods for modulating regulatory T cells, regulatory b cells, and immune respon2024
Small molecules for inducing selective protein degradation and uses thereof2023
Small molecules for inducing selective protein degradation and uses thereof2023
Small molecules that block proteasome-associated ubiquitin receptor RPN13 functi2023
Small molecules that block proteasome-associated ubiquitin receptor RPN13 functi2023
Immunogenic peptides specific to BCMA and TACI antigens2022
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a pro2022
Inhibitors of histone deacetylase2022